Multiple Sclerosis Trial, By Invitation
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are able to read, understand, and sign a consent form on their own, without assistance.
- People who are able to follow the study's procedures, including having a mobile phone or device that can run an app called "icompanion."
- People who have a confirmed diagnosis of Multiple Sclerosis (MS), or a diagnosis of an early or possible form of MS called RIS (Radiologically Isolated Syndrome) or CIS (Clinically Isolated Syndrome), whether or not they are currently on treatment.
- People who are either early in their MS disease course — including those with CIS, RIS, or relapsing-remitting MS (RRMS) diagnosed less than 7 years ago — or people with a relapsing MS diagnosis who have had the condition for between 12 and 18 years (a stage where the disease may be changing in nature).
- People who have existing medical records, including brain scan (MRI) results, from at least one year before the study begins.
- People aged 18 years or older.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are unable or unwilling to read, understand, or sign the consent form.
- People for whom having an MRI scan is not medically safe (confirm with trial site).
- People who are currently taking part in another clinical trial that involves an active treatment or intervention.
- People who are currently pregnant or who are planning to become pregnant within the next two years.
- People who have another health condition that may require long-term use of steroid tablets or immune-suppressing medicines during the study.
- People whose existing MRI scans do not meet the study's technical requirements — specifically, the scans must include certain types of images (3D T1-weighted images and FLAIR images meeting minimum quality standards).
- People who have a confirmed diagnosis of Primary Progressive MS (PPMS), which is a specific form of MS that progresses from the start without relapses.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Impact of using icobrain mr on detecting (inflammatory or smouldering) disease activity; Impact of using icobrain mr on the clinical outcome
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.